Main Industry
Health Care
Main Product/Service
Antibody drug development, production and research of peptides and microorganisms, development of antibody purification technologies, long-acting drug-release gels, drug-loaded contact lenses, nanogel drug encapsulation technology, small-molecule anti-cancer drug development, and health food development.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2014
Unified Business No.
24537679
Status
Active
Number of Employees
20
Total Paid-in
Capital
80,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
SAGABIO CO., LTD. is a team composed of professionals in medicine, nutrition, food science, and other fields, and is a biotechnology company with a background in novel drug research and development. Dr. Kuan-Wen Chen, CEO of SAGABIO CO., LTD., inherits the philosophy established by the founder, Jung-Hsiang Chen, actively developing biomedical and biotechnological research and development and cooperating with Taiwanese academic institutions. Its technology transfer partners include Taipei Medical University, National Taiwan Ocean University, National Taipei University of Technology, National Defense Medical Center, National Chiao Tung University, and the Development Center for Biotechnology, among others, while also cooperating with related fields in the industry.
(The content above was translated by AI.)
(The content above was translated by AI.)
